Tag: Stem Cells + Therapeutic Cloning

Prominent stem cell group honors Whitehead Member Rudolf Jaenisch

February 24, 2012

The International Society for Stem Cell Research (ISSCR) has named Whitehead Institute Founding Member Rudolf Jaenisch the winner of the 2012 McEwen Award for Innovation.

Not all cellular reprogramming is created equal

December 1, 2011

Tweaking the levels of factors used during the reprogramming of adult cells into induced pluriopotent stem (iPS) cells can greatly affect the quality of the resulting iPS cells, according to Whitehead Institute researchers. This finding explains at least in part the wide variation in quality and fidelity of iPS cells created through different reprogramming methods.

Novel surface triples stem-cell growth in culture

November 7, 2011

By irradiating typical polystyrene lab plates with ultraviolet (UV) waves, Whitehead Institute and MIT scientists have created a surface capable of tripling the number of human embryonic stem (ES) and induced pluripotent stem (iPS) cells that can be grown in culture by current methods.

Diagram of cancer cell type equilibrium

Cancer stem cells made, not born

August 18, 2011

New findings by scientists at the Broad Institute of MIT and Harvard and Whitehead Institute point to a decentralized society in tumors, with cancer cells able to interconvert between different types. These results have potential implications for the treatment of tumors, in particular, that attacking cancer stem cells alone may not be enough to fight cancer.

Precision gene targeting in stem cells corrects disease-causing mutations

July 14, 2011

Using two distinct methods, Whitehead Institute researchers have successfully and consistently manipulated targeted genes in both human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells (adult cells that have been reprogrammed to an embryonic stem cell-like state).

Image of epithelial and mesenchymal cells

Signaling pathways point to vulnerability in breast cancer stem cells

June 9, 2011

Whitehead Institute researchers have identified signals impinging on breast epithelial cells that can induce those cells to acquire and stably display migratory and self-renewing characteristics.

Image of a planarian

Pluripotent adult stem cells power planarian regeneration

May 12, 2011

Whitehead Institute researchers have determined that the planarian flatworm regenerates missing tissues by using pluripotent adult stem cells. Until now, scientists could not determine whether the dividing cells in planarians, called neoblasts, are a mixture of specialized stem cells that each regenerates specific tissues, or if individual neoblasts are pluripotent and able to regenerate all tissues.

Ancient gene gives planarians a heads-up in regeneration

May 12, 2011

A little-studied gene known as notum plays a key role in the planarian’s regeneration decision-making process, according to Whitehead Institute scientists. At head-facing (anterior) wounds, the gene notum acts as a dimmer switch to dampen the Wnt pathway—an ancient signaling circuit that operates in all animals—and promote head regeneration.

Scientists identify a surprising new source of cancer stem cells

April 11, 2011

Certain differentiated cells in breast tissue can spontaneously convert to a stem-cell-like state, according to Whitehead Institute researchers. Until now, scientific dogma has stated that differentiation is a one-way path; once cells specialize, they cannot return to the flexible stem-cell state on their own.

Human embryonic stem cells and reprogrammed cells virtually identical

August 5, 2010

Human embryonic stem (ES) cells and adult cells reprogrammed to an embryonic stem cell-like state—so-called induced pluripotent stem or iPS cells—exhibit very few differences in their gene expression signatures and are nearly indistinguishable in their chromatin state, according to Whitehead Institute researchers.

Protein that predicts prognosis of leukemia patients may also be a therapeutic target

July 8, 2010

Researchers at Whitehead Institute and Children’s Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients. High levels of Musashi 2 protein is associated with increased cell proliferation, decreased cell maturation, and multiple cancer-related cellular pathways in human leukemias.

Image of purple intestinal epithelial cells extracted from a teratoma seeded by reprogrammed blood cells.

Reprogrammed human blood cells show promise for disease research

July 1, 2010

Cells from frozen human blood samples can be reprogrammed to an embryonic stem-cell-like state, according to Whitehead Institute researchers. These cells can be multiplied and used to study the genetic and molecular mechanisms of blood disorders and other diseases.

Pages

© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142